title: Maximal coronary vasodilator capacity of orthotopic heart transplants in patients with and without rejection.
abstract: In cardiac allograft rejection, histopathologic changes suggesting that myocardial ischemia is a component of the rejection process have been documented. To further define the coronary vascular reactivity of human heart transplant, coronary sinus blood flow and coronary resistance were measured before and after intravenous dipyridamole within the first year after transplantation in 8 patients without rejection (group II) and in 5 patients with rejection (group III). All had normal coronary arteriograms. Results were compared to those of 8 control subjects (group I). After dipyridamole, coronary sinus blood flow was increased in groups I, II and III by 303, 212 (p less than 0.01 vs group I) and 45%, respectively (p less than 0.001 vs groups I and II). Coronary resistance was reduced by 77, 73 (not significant vs group I) and 36%, respectively (p less than 0.001 vs groups I and II). Concomitantly, coronary sinus blood oxygen content was increased by 172, 145 (not significant vs group I) and 78%, respectively (p less than 0.001 vs group I, not significant vs group II). Thus, the coronary flow reserve evaluated by the dipyridamole/basal coronary sinus blood flow ratio and the coronary resistance reserve evaluated by the basal/dipyridamole coronary resistance ratio were dramatically impaired in group III (1.56 +/- 0.09 and 1.63 +/- 0.30, respectively, p less than 0.001 vs groups I and II). In contrast, they were almost normal in group II (3.11 +/- 0.42 vs 4.03 +/- 0.52 in group I, p less than 0.02, and 3.83 +/- 0.78 vs 4.45 +/- 0.81 in group I, difference not significant). Thus, the impairment of coronary reserve during heart rejection should be linked to abnormalities of the coronary microvaculature. This emphasizes the important involvement of the coronary circulation in the rejection process.
authors.affiliation: Service de Physiologie et d'Explorations Fonctionnelles, Institut National de la Santé et de la Recherche Médicale Unité 251, Centre Hospitalier Universitaire Xavier-Bichat, Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Nitenberg
authors.forename: O
authors.initials: O
authors.lastname: Tavolaro
authors.forename: D
authors.initials: D
authors.lastname: Loisance
authors.forename: J M
authors.initials: JM
authors.lastname: Foult
authors.forename: L
authors.initials: L
authors.lastname: Hittinger
authors.forename: E
authors.initials: E
authors.lastname: Aptecar
authors.forename: J P
authors.initials: JP
authors.lastname: Cachera
mesh_terms: D000328:Adult; D000368:Aged; D000792:Angiography; D017023:Coronary Angiography; D003331:Coronary Vessels / Q000503:physiopathology*; D004176:Dipyridamole; D005260:Female; D006084:Graft Rejection; D016027:Heart Transplantation; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000378:metabolism; D012016:Reference Values; D014664:Vasodilation
chemical_list: D004176:Dipyridamole